首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   92414篇
  免费   5777篇
  国内免费   2602篇
耳鼻咽喉   1363篇
儿科学   1015篇
妇产科学   1088篇
基础医学   13920篇
口腔科学   1822篇
临床医学   8952篇
内科学   15825篇
皮肤病学   2578篇
神经病学   6063篇
特种医学   4629篇
外国民族医学   7篇
外科学   10959篇
综合类   5497篇
现状与发展   5篇
一般理论   19篇
预防医学   4985篇
眼科学   2166篇
药学   8989篇
  45篇
中国医学   3151篇
肿瘤学   7715篇
  2024年   969篇
  2023年   1282篇
  2022年   2806篇
  2021年   3962篇
  2020年   2403篇
  2019年   2647篇
  2018年   2944篇
  2017年   2451篇
  2016年   3058篇
  2015年   4334篇
  2014年   5058篇
  2013年   5503篇
  2012年   8030篇
  2011年   7587篇
  2010年   4676篇
  2009年   3833篇
  2008年   5147篇
  2007年   4794篇
  2006年   4242篇
  2005年   3865篇
  2004年   3153篇
  2003年   2945篇
  2002年   2526篇
  2001年   2241篇
  2000年   1942篇
  1999年   1466篇
  1998年   710篇
  1997年   587篇
  1996年   460篇
  1995年   384篇
  1994年   342篇
  1993年   266篇
  1992年   466篇
  1991年   452篇
  1990年   410篇
  1989年   359篇
  1988年   328篇
  1987年   314篇
  1986年   241篇
  1985年   205篇
  1984年   142篇
  1983年   121篇
  1982年   67篇
  1981年   78篇
  1980年   55篇
  1979年   97篇
  1978年   73篇
  1974年   65篇
  1973年   56篇
  1972年   56篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
121.
122.

Background and objectives

An ultrasound guided femoral nerve block is an established analgesic method in patients with a hip fracture. Elevated cytokine levels correlate with poor patient outcomes after surgery. Hence, the aim of the study was to describe the levels of tumor necrosis factor‐α after an ultrasound‐guided femoral nerve block in elderly patients having a femoral neck fracture.

Methods

A total of 32 patients were allocated into two treatment groups: 16 patients (femoral nerve block group; ultrasound‐guided femoral nerve block with up to 20 mL of 0.3 mL.kg?1 of 0.5% bupivacaine and intravenous tramadol) and 16 patients (standard management group; up to 3 mL of 0.9% saline in the femoral sheath and intravenous tramadol). Tumor necrosis factor‐α and visual analogue scale scores were evaluated immediately before the femoral nerve block and again at 4, 24, and 48 h after the femoral nerve block. All surgery was performed electively after 48 h of femoral nerve block.

Results

The femoral nerve block group had a significantly lower mean tumor necrosis factor‐α level at 24 (4.60 vs. 8.14, p < 0.001) and 48 h (5.05 vs. 8.56, p < 0.001) after the femoral nerve block, compared to the standard management group. The femoral nerve block group showed a significantly lower mean visual analogue scale score at 4 (3.63 vs. 7.06, p < 0.001) and 24 h (4.50 vs. 5.75, p < 0.001) after the femoral nerve block, compared to the standard management group.

Conclusions

Ultrasound‐guided femoral nerve block using 0.3 mL.kg?1 of 0.5% bupivacaine up to a maximum of 20 mL resulted in a significant lower tumor necrosis factor‐α level.  相似文献   
123.

Background

Although renal function recovery of living kidney donors has been reported in a number of studies, many patients show poor recovery, and the long-term prognosis of these patients has not been well studied. In this investigation we explored the long-term prognosis of renal function in patients with chronic kidney disease (CKD) at 1 year after nephrectomy.

Methods

Patients who underwent donor nephrectomy during the period from March 2006 to April 2014, with a follow-up creatinine study at 1 year postoperatively and more than 3 years of follow-up, were included in the study. Creatinine and estimated glomerular filtration rate (eGFR, using the Modification of Diet in Renal Disease formula) before and after surgery were studied. Age, sex, history of hypertension or diabetes, body mass index, blood pressure, complete blood count, preoperative routine serum chemistry, and urine study results were reviewed.

Results

Among 841 patients who had donor nephrectomy, 362 were included in the study. There were 111 patients (30.6%) with eGFR <60 mL/min/1.73 m2 at 1 year postsurgery, and the median follow-up period was 62.8 months (interquartile range [IQR] 42.0–86.3 months). The maximum eGFR after 3-year follow-up was studied, and 48 patients (43.2%) never recovered eGFR to >60 mL/min/1.73 m2. Age, history of hypertension, preoperative eGFR, and eGFR at 1 year were predictive factors at univariate analysis. Multivariate analysis of these factors was studied, and age (52.5 [IQR 47–55.7] vs 47 [IQR 7–53] years, odds ratio [OR] 1.1, 95% confidence interval [CI] 1.02–1.15, P = .007), history of hypertension (16.7% vs 1.6%, OR 10.0, 95% CI 1.09–92.49, P = .042), and eGFR at 1 year (53.9 [IQR 50.3–56.0] vs 57.0 [IQR 54.2–58.4] mL/min/1.73 m2, OR 0.8, 95% CI 0.72–0.92, P = .002) remained as significant risk factors.

Conclusion

Of all living donors, 15.7% had CKD after >3 years of follow-up. Close observation is warranted when donors have CKD after 1 year follow-up, as 43.2% fail to recover renal function. Patients who are older, have a history of hypertension, and have low eGFR at 1-year follow-up are especially at risk.  相似文献   
124.

Background

Comorbid conditions are important in the survival of kidney transplant recipients. The weights assigned to comorbidities to predict survival may vary based on the type of index disease and advances in the management of comorbidities. We aimed to develop a modified Charlson comorbidity index (CCI) in renal allograft recipients (mCCI-KT), thereby improving risk stratification for mortality.

Methods

A total of 3765 recipients in a multicenter cohort were included to develop a comorbidity score. The weights of the comorbidities, per the CCI, were recalibrated using a Cox proportional hazards model.

Results

Peripheral vascular disease, liver disease, myocardial infarction, and diabetes in the CCI were selected from the Cox proportional hazards model. Thus, the mCCI-KT included 4 comorbidities with recalibrated severity weights. Whereas the CCI did not discriminate for survival, the mCCI-KT provided significant discrimination for survival using the Kaplan-Meier method and Cox regression analysis. The mCCI-KT showed modest increases in c-statistics (0.54 vs 0.52, P = .001) and improved net mortality risk reclassification by 16.3% (95% confidence interval, 3.2–29.4; P = .015) relative to the CCI.

Conclusion

The mCCI-KT stratifies the risk for mortality in renal allograft recipients better than the CCI, suggesting that it may be a preferred index for use in clinical practice.  相似文献   
125.
126.

Background

Gas exchange disturbance may develop during urologic robotic laparoscopic surgery with the patient in a steep Trendelenburg position. This study investigated whether prolonged inspiratory time could mitigate gas exchange disturbances including hypercapnia.

Methods

In this randomized cross-over trial, 32 patients scheduled for robot-assisted urologic surgery were randomized to receive an inspiratory to expiratory time ratio (I:E) of 1:1 for the first hour of pneumoperitoneum followed by 1:2 for last period of surgery (group A, n?=?17) or I:E of 1:2 followed by 1:1 (group B, n?=?15). Arterial blood gas analysis, airway pressure and hemodynamic variables were assessed at four time points (T1: 10?min after induction of general anesthesia, T2: 1?h after the initiation of pneumoperitoneum, T3: 1?h after T2 and T4: at skin closure). The carry over effect of initial I:E was also evaluated over the next hour through arterial blood gas analysis.

Results

There was a significant decrease in partial pressure of oxygen in arterial blood (PaO2) for both groups at T2 and T3 compared to T1 but in group B the PaO2 at T4 was not decreased from the baseline. Partial pressure of carbon dioxide in arterial blood (PaCO2) increased with I:E of 1:2 but did not significantly increase with I:E of 1:1; however, there were no differences in PaO2 and PaCO2 between the groups.

Conclusion

Decreased oxygenation by pneumoperitoneum was improved and PaCO2 did not increase after 1 h of I:E of 1:1; however, the effect of equal ratio ventilation longer than 1 h remains to be determined. There was no carryover effect of the two different I:E ratios.
  相似文献   
127.
128.
129.
130.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号